Login
$CLCS
$0.52 -$0.22 (29.81%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Assets
Current Assets:
Cash
Prepaid expenses
Prepaid expenses - research and development
Subscription receivable
Other current assets
Total Assets
Liabilities and Stockholders’ Deficiency
Current Liabilities:
Accounts payable
Accrued expenses
Nonrelated Party
Related Party
Total accrued expenses
Accrued expenses - related parties
Accrued interest
Nonrelated Party
Related Party
Total accrued interest
Accrued interest - related parties
Accrued compensation
Notes payable
Nonrelated Party
Related Party
Total notes payable
Notes payable - related parties
Convertible notes payable, net of debt discount of $12,756 and $71,124 as of March 31, 2022 and December 31, 2021, respectively
Convertible notes payable
Nonrelated Party
Related Party
Total convertible notes payable
Convertible notes payable - related parties, net of debt discount of $147,230 and $0 as of December 31, 2022 and 2021, respectively
Warrant liabilities
Nonrelated Party
Related Party
Derivative liabilities
Nonrelated Party
Related Party
Total derivative liabilities
Financing liability
Advances payable
Nonrelated Party
Related Party
Total advances payable
Advances payable - related party
Advances payable - related party
Nonrelated Party
Related Party
Accrued dividend payable
Total accrued dividend payable
Total Liabilities
Stockholders’ Deficiency:
Preferred stock, value
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Common Stock, $0.001 par value, 200,000,000 shares authorized; 45,038,244 shares issued and outstanding as of March 31, 2025 and December 31, 2024
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Deficiency
Total Liabilities and Stockholders’ Deficiency

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support